The composition of the medicament includes several components that have anti-inflammatory and anti-infectious effects on the body. So, the main active substances are bromhexine and guaifenesin. Salbutamol may also be included. These substances are mutually complementary. Both substances have mucolytic properties, which are manifested in the fact that the drug dissolves sputum and promotes its excretion from the body.
Accordingly, the inflammatory process decreases, recovery comes faster. The second substance has mainly bronchodilator properties, since it can effectively eliminate the inflammatory process, normalize the condition of the alveoli. As a result, the contractility of the bronchi is normalized, and optimal conditions for accelerated excretion of diluted sputum from the body are added.
In addition, both drugs quite quickly and effectively eliminate irritation and hyperemia of the mucous membranes, having a positive effect, both on the walls of the respiratory tract and on the mucous membranes. Effectively affects the bronchi, lungs, respiratory tract, trachea. An additional property of the complex of preparations is the prevention of bronchopulmonary spasm, which contributes to the effective elimination of spasmodic phenomena.
In addition to the properties described above, the drug has the ability to reduce resistance in the airways, reduce alveolar pressure, which contributes to an increase in pulmonary volume and normalization of bronchial conductivity. As a result, the cells' ability to saturate with oxygen increases and accelerated removal of carbon dioxide from the body. This reduces the degree of viral and bacterial load on the body, and also eliminates intoxication syndrome.
As an additional property of the drug, its ability to affect the receptors of blood vessels is considered, as a result of which the drug can be attributed to adrenostimulators. The main target of these drugs are the receptors located in the bronchi, and blood vessels, localized mainly in the mucous membranes. Among the competitive advantages of this drug can be attributed to their property, such as high speed of action. This effect can largely be achieved through vasodilator action.
In addition to the main effect, the drug has a mild immunostimulating effect, due to which there is active secretion of the mucous membranes, which has an antiseptic effect on the body, facilitates the dilution of sputum and its complete excretion from the body.
Bromhexine, which is part of the drug, also has antitussive effects on the body, which can be achieved through stimulating effects on the body, and primarily on the cilia of the ciliated epithelium. Also, as another competitive advantage, it is worth noting the ability of the drug to achieve fairly high rates of the positive impact on the body, which can be achieved through a high rate of absorption of the active substance through the walls of blood vessels, its effective penetration into lymph and blood, rapid spread to target organs and tissues.
In addition, due to the action of this drug, the amount of sputum can dramatically increase. Accordingly, its ability to accelerate excretion from the body also increases. It is also worth noting that due to the ability to eliminate spasms and inflammatory processes in the bronchi and lung tissue, it becomes possible to go out that sputum, which is stagnant in the bronchioles and alveoli. It is for this reason that there is an increase in sputum production.
It should be borne in mind that bromhexine is a drug of accumulative action, that is, it has the ability to accumulate in the body. Accordingly, with each subsequent case of the disease, a much lower dosage of the drug will be required to achieve the desired therapeutic effect.
Guaifenesin is a substance of plant origin, which has long been used for medical purposes. It was first used in India for the treatment of inflammatory diseases of the bronchi and lungs. The source of this substance is the guaiac tree. First of all, the drug is known for its high secretory activity and directly affects the bronchial cells. The drug stimulates the increased production of sputum secretory cells of the bronchi, so it becomes more viscous, promotes greater excretion, and accordingly, the speedy removal of the inflammatory process and the anti-infective action.
When taking ascoril, stagnant phenomena do not occur due to the fact that all active substances are directed directly at reducing the inflammatory process and eliminating sputum. The advantage of the drug is that it prevents the accumulation of bacterial microflora in the body. Accordingly, the probability of development of the infectious process decreases. The emergence of new foci of infection is practically not possible. The drug can be taken with a dry cough, which is not accompanied by sputum. The fact is that in this case, it promotes the excretion of phlegm from the body by transferring a dry, unproductive cough into a productive, moist cough, accompanied by an anti-inflammatory effect.
Also, as an additional active ingredient is menthol, the effect of which is aimed at expanding the bronchi, dilution and complete dissolution of bronchial secretion, antiseptic effect on the body.